Here are relevant reports on : gene-therapy-market
-
Ultrasonic Tissue Ablation System Market by Type (HIFU Ablators, MRGFUS Ablators, Ultrasonic Surgical Ablation, Shock Wave Therapy Systems), Application (Cardiac Diseases, Cancer, Pain Management) & End User (Hospitals, Clinics) - Global Forecast to 2023
The global ultrasonic tissue ablation system market is expected to reach USD 1,449.2 million by 2023 from USD 840.9 million in 2018, growing at a CAGR of 11.5%. Increasing prevalence of chronic diseases; rising adoption of minimally invasive surgeries; ongoing technological advancements in the field of ablation devices, growing awareness about benefits of ablation procedures over conventional therapeutic and surgical procedures, and rising number of hospitals and surgical centers are some of the major factors driving the growth of the global suture anchor market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Intraoperative Radiation Therapy Market Size, Share & Trends by Technology (Electron IORT, Brachytherapy), Products & Services (Accelerators, Treatment Planning system, Applicators, Afterloaders, Accessories), Application (Breast, Brain, Lung Cancer) & Region - Global Forecast to 2025
The global intraoperative radiation therapy market in terms of revenue was estimated to be worth USD 48 million in 2020 and is poised to reach USD 66 million by 2025, growing at a CAGR of 6.4% from 2020 to 2025. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) & Region - Global Forecast to 2028
The global stem cell therapy market, valued at US$259 million in 2022, stood at US$286 million in 2023 and is projected to advance at a resilient CAGR of 16.5% from 2023 to 2028, culminating in a forecasted valuation of US$615 million by the end of the period. Market growth is driven mainly by factors such as rise in funding for stem cell research, upsurge in the number of cell therapy production facilities that have GMP certification, and increased in the number of clinical trials associated with stem cell therapies.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Continuous Renal Replacement Therapy Market by Product (Hemofilter, Bloodline, Machines, Dialysates), Modality (SCUF, CVVH, CVVHD, CVVHDF), Age (Adult, Pediatric), Enduser (Hospitals, Ambulatory), and Region - Global Forecast to 2028
The global continuous renal replacement therapy market, valued at US$1.3 billion in 2022, stood at US$1.4 billion in 2023 and is projected to advance at a resilient CAGR of 8.1% from 2023 to 2028, culminating in a forecasted valuation of US$2.1 billion by the end of the period. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and rising incidences of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to accelerate the growth of the market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Elastomeric Pumps Market by Product (Continuous Rate, Variable Rate), Treatment (Chemotherapy, Antibiotic, Iron Chelation Therapy), Administration Route (Intravenous, Subcutaneous), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022
The global elastomeric pumps market is expected to reach USD 592.0 Million by 2022 from USD 432.1 Million in 2017, growing at a CAGR of 6.5% from 2017 to 2022. Increasing number of surgeries, wide usage in treatment, rising incidence of chronic diseases, and increasing adoption for disposable infusion pumps, are some of the major driving factors driving the growth of the global elastomeric pumps market. However, the high cost of treatment and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Healthcare Market Outlook – [By Health Indicators (Life Expectancy, Mortality), Disease Burden (Epidemiology, Average Cost Of Therapy), Health System (Infrastructure, Expenditure), Regulatory Landscape] - Analysis & Forecast To 2020
The APAC region showcases diverse healthcare challenges across various countries. These range from improving healthcare access in developing countries of Vietnam to tackling rising diabetes, cancer, and cardiovascular diseases in well developed nations of Japan and Pacific countries. In addition, regions of China and India that lie in between developing and well developed countries are facing increase in diseases burden, problems of poverty, limited access to high quality treatment, and slow increase in disposable income. The APAC Healthcare Market Outlook examines the health indicators and healthcare system across India, China, Japan, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Australia, and New Zealand. The APAC Healthcare Market Outlook is segmented into five broad categories: health status, healthcare system assessment, healthcare regulatory landscape, medical devices infrastructure assessment, hospital chain assessment in top 10 hospitals.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Robotic Radiotherapy Market Size by Product (System, Software, 3D Camera), Technology (LINAC, Stereotactic, Particle Therapy), Application (Lung, Breast, Colorectal), End-User (Hospitals, Radiotherapy Centres), & Region - Global Forecast to 2028
The global robotic radiotherapy market, valued at US$0.8 billion in 2021, stood at US$1.1 billion in 2023 and is projected to advance at a resilient CAGR of 11.9% from 2023 to 2028, culminating in a forecasted valuation of US$1.9 billion by the end of the period. The market's expansion is driven by several factors, including the global rise in cancer cases, advancements in automation technologies enhancing the precision of radiotherapy, a growing preference for non-invasive cancer treatments, and the rapid proliferation of cancer treatment facilities.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Gold Nanoparticles Market by Process (Physical, Chemical, Biological), Application (Imaging, Targeted Drug Delivery, Proton Therapy, In-Vitro Assays, Sensors, Probes, Catalysis), End-Use Industry and Region - Global Forecast to 2029
The gold nanoparticles market is expected to grow from USD 0.50 billion in 2024 to USD 1.11 billion in 2029, at a CAGR of 16.3% during the forecast period. Prominent companies include BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US), NanoHybrids (US), Sona Nanotech (Canada), Sisco Research Laboratories Pvt, Ltd. (India), Nanoprobes, Inc (US), American Elements (US), TORSKAL (France), Abcam Limited (UK), Particular GmbH (Germany), Dongguan Sat Nano Technology Material Co., Ltd (China), Nano Flow (Belgium), Strem Catalog (US), Nanorh (India), SkySpring Nanomaterials (US), Aurion (Netherlands), NNCrystal US Corporation (US), and among others.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030
The global AI in Precision Medicine market, valued at US$0.60 billion in 2023, stood at US$0.78 billion in 2024 and is projected to advance at a resilient CAGR of 30.7% from 2024 to 2030, culminating in a forecasted valuation of US$3.92 billion by the end of the period. Growth in precision medicine, AI’s efficiency in drug discovery, integration of Real-World Evidence (RWE) in emerging markets to drive the market significantly.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Compression Therapy Market by Technique (Static, Dynamic), Product (Bandage, Wraps, Stockings, Tapes, Braces, Pneumatic), Application (Varicose Vein, DVT, Lymphedema, Ulcers), Distribution Channel (Clinics, Pharmacy, E-Commerce) - Global Forecasts to 2030
Global compression therapy market valued at $4.3B in 2024, reached $4.5B in 2025, and is projected to grow at a robust 5.5% CAGR, hitting $5.9B by 2030. The key factor driving the compression therapy market is the increasing prevalence of venous disorders and lymphedema, particularly among the elderly and post-surgical patients. Additionally, the rising rates of obesity and advancements in smart compression devices are further boosting demand in this market.
- Published: May 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
